Publications by authors named "Daniel Provost"

Claim this Profile
E
Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner.
Philipp Kalk, Yuliya Sharkovska, Elena Kashina, Karoline von Websky, Katharina Relle, Daniel Provost

Hypertension· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
Gerard H Thomas, Adam J Babbs, Rosemary E Chatfield, Thomas M Krülle, Peter S Widdowson, Daniel Provost

Obesity (Silver Spring)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models of cardiovascular disease: measurement of arrhythmogenic/antiarrhythmic activity in the guinea pig.
Philippe Guillaume, Daniel Provost, Pierre Lacroix

Curr Protoc Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models of cardiovascular disease: measurement of antihypertensive activity in the conscious rat (SHR, DOCA-salt, and Goldblatt hypertension models).
Philippe Guillaume, Daniel Provost, Pamela Legrand, Michael Godes, Pierre Lacroix

Curr Protoc Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal models: intestinal transit, gastric emptying, and ulcerogenic activity in the rat.
Philippe Guillaume, Daniel Provost, Pierre Lacroix

Curr Protoc Pharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis